Publications
Similar Clinical Improvement Rates Among Biologic Drug Classes in Crohn’s Disease: Systematic Review and Meta-Regression
Citation
Jurij Hanžel, Rocio Sedano, Jenny Jeyarajah, Guangyong Zou, Stefanie C McFarlane, Christopher Ma, Vipul Jairath. Similar Clinical Improvement Rates Among Biologic Drug Classes in Crohn's Disease: Systematic Review and Meta-Regression. Inflamm Bowel Dis. 2022 Feb 15;izac018. DOI: 10.1093/ibd/izac018. Online ahead of print. PMID: 35166778 DOI: 10.1093/ibd/izac018.
Abstract
Plain language summary
We conducted a systematic review and metaregression of pivotal Crohn’s disease trials to evaluate the rates of change in Crohn’s Disease Activity Index scores in patients receiving biologic treatments. The speed of clinical improvement was similar among biologic drug classes.